SPX-101

Blocks the function of sodium channel in lungs, maintaining fluid to improve mucus clearance

Phase of research

Phase Two Clinical Trial

How it helps

Mucociliary Clearance

General information

N/A

Synonyms

N/A

Marketed as

N/A

Dietary sources

N/A

Structure image not available

N/A

Drug-Mutation Relation

Treats

Mutation Number of sources Average impact factor
General effect
2 9.77
Link Tested on Impact factor Notes
SPX-101 is stable in and retains function after exposure to cystic fibrosis sputum. mice 4.29
SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport. mice 15.24

Does not treat

Mutation Number of sources Average impact factor